Skip to main content

Table 1 Sociodemographic, clinical, and laboratory data for individuals included in the study categorized according to the presence (Group 1 + Group 3) or absence (Group 2 + Group 4) of TB

From: Clinical and genetic markers associated with tuberculosis, HIV-1 infection, and TB/HIV-immune reconstitution inflammatory syndrome outcomes

FeaturesOverall
N = 162
With TB
(G1 + G3)
N = 112
Without TB
(G2 + G4)
N = 50
P-valuea
Gender; n (%)
 Female49 (30.2)26 (23.21)23 (46)0.005
 Male113 (69.8)86 (76.79)27 (54) 
Skin Colorb; n (%)
 Black32 (19.8)25 (22.32)7 (14)0.379
 Brown64 (39.5)41 (36.61)23 (46) 
 White66 (40.7)46 (41.07)20 (40) 
Educationc; n (%)
 Bachelor13 (8)6 (5.36)7 (14)<0.001
 Upper-secondary49 (30.2)27 (24.11)22 (44) 
 Lower-secondary67 (41.4)46 (41.07)21 (42) 
 Primary26 (16)26 (23.21)0 (0) 
 Unknown7 (4.3)7 (6.25)0 (0) 
HIV status; n (%)
 Negative50 (30.9)24 (21.43)26 (52)0.0002
 Positive112 (69.1)88 (78.57)24 (48) 
CD4 count (cell/μL) (IQR)153 (654.25)130.5 (116.51)674 (1348)0.003
 (≤50); n (%)40 (25.3)28 (25)12 (24)0.846
 (>50); n (%)118 (74.7)80 (71.43)38 (76) 
CD8 (IQR)588 (562)591 (527.7)564 (1.128) 
 (≤500); n (%)65 (42.5)44 (39.28)21 (42)1
 (>500); n (%)88 (57.5)59 (52.68)29 (58) 
CD4/CD8 (IQR)0.29 (0.96)0.2 (0.18)0.69 (1.38)0.004
 (≤1); n (%)111 (72.5)85 (75.89)26 (52)0.0002
 (>1); n (%)42 (27.5)18 (16.07)24 (48) 
  1. N number of individuals in each group, TB tuberculosis, IQR interquartile range, VL viral load, G1 group 1, G2 group 2, G3 group 3, G4 group 4
  2. aP-values were calculated using Fisher’s exact test. Differences were considered significant with a value of * P < 0.05. Significant P-values are labeled in bold. bSkin color categorization followed the classificatory system employed by the Brazilian Institute of Geography and Statistics (IBGE) [59]. cClassification, according to the International Standard Classification of Education (ISCED) maintained by the United Nations Educational, Scientific and Cultural Organization (UNESCO)